Business Wire LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Companys second quarter 2023 financial results will be released before market open on Wednesday...\n more…